Article info
PDFPostScript
Letter
Contamination with gangliosides in brain-derived rabies vaccine may trigger Guillain–Barré syndrome
- Correspondence to Professor Nobuhiro Yuki, Department of Microbiology, National University of Singapore, Block MD4A, Level 5, 5 Science Drive 2, Singapore 117597, Singapore; micyuki{at}nus.edu.sg
Citation
Contamination with gangliosides in brain-derived rabies vaccine may trigger Guillain–Barré syndrome
Publication history
- Received August 2, 2011
- Revised August 21, 2011
- Accepted August 24, 2011
- First published September 23, 2011.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.